PAR logo

PAR

PAR Technology Corporation

$15.29
+$0.44(+2.96%)
56
Overall
60
Value
63
Tech
47
Quality
How is this score calculated?
Market Cap
$1.57B
Volume
1.54M
52W Range
$11.59 - $72.15
Target Price
$28.44

Company Overview

Mkt Cap$1.57BPrice$15.29
Volume1.54MChange+2.96%
P/E Ratio-18.6Open$14.85
Revenue$455.5MPrev Close$14.85
Net Income$-84.5M52W Range$11.59 - $72.15
Div YieldN/ATarget$28.44
Overall56Value60
Quality47Technical63

No chart data available

About PAR Technology Corporation

PAR Technology Corporation, together with its subsidiaries, provides omnichannel cloud-based hardware and software solutions to the worldwide. The company offers PUNCHH, an enterprise-grade customer loyalty and engagement solution; PAR ORDERING, an e-commerce platform; PAR RETAIL, a digital engagement software solution; and PLEXURE, an international customer engagement and loyalty platform under the ENGAGEMENT CLOUD. It also provides PAR POS, a point-of-sale solution; TASK, an enterprise-grade technology solution; PAR OPS, which includes Data Central and Delaget; and PAR PAY, such as PAR payment services, and merchant services under the OPERATOR CLOUD. In addition, the company offers point-of-sale terminals and tablets, wireless headsets, drive-thru systems, kitchen display systems, kiosks, printers, payment devices, and other in-store peripherals. Further it provides services, such as hardware repair, installation and implementation, training, and on-site and technical support services. It serves enterprise restaurants, franchisees, and other restaurant outlets and to C-Stores; and other retail customers, including amusement parks, cinemas, cruise lines, spas, casinos, and other ticketing and entertainment venues. The company was founded in 1968 and is headquartered in New Hartford, New York.

Sector: Technology
Industry: Software - Application

Latest News

Paradigm Biopharmaceuticals Updates Director Matthew Fry’s Option Holdings

The latest update is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has disclosed a change in the indirect interes...

TipRanks Australian Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals updates market on director Paul Rennie’s expanded option holdings

TipRanks Australian Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals Seeks ASX Quotation for Over 10 Million New Shares

TipRanks Australian Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals’ Top 20 Option Holders Control Majority of PAROPTWC Register

TipRanks Australian Auto-Generated Newsdesk4 days ago

Paradigm Biopharmaceuticals Seeks ASX Quotation for 117 Million New Options

TipRanks Australian Auto-Generated Newsdesk4 days ago
ABCD
1SymbolPriceChangeVol
2PAR$15.29+3.0%1.54M
3
4
5
6

Get PAR Technology Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.